Open access · CC-BY
via OpenAlex
Sarcopenia and diabetes: Hyperglycemia is a risk factor for age‐associated muscle mass and functional reduction
Journal of Diabetes Investigation · 2015 · ▲ 123 citations
Abstract
Kalyani et al. recently reported that hyperglycemia is associated with sarcopenia. Blood-glucose-lowering therapy may prevent the progression of sarcopenia in subjects with D<\M.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/jdi.12365
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Umegaki, H. (2015). Sarcopenia and diabetes: Hyperglycemia is a risk factor for age‐associated muscle mass and functional reduction. <em>Journal of Diabetes Investigation</em>. https://doi.org/10.1111/jdi.12365
Vancouver
Umegaki H. Sarcopenia and diabetes: Hyperglycemia is a risk factor for age‐associated muscle mass and functional reduction. Journal of Diabetes Investigation. 2015. doi:10.1111/jdi.12365.
BibTeX
@article{hiroyuki2015Sarcop,
title = {Sarcopenia and diabetes: Hyperglycemia is a risk factor for age‐associated muscle mass and functional reduction},
author = {Hiroyuki Umegaki},
journal = {Journal of Diabetes Investigation},
year = {2015},
doi = {10.1111/jdi.12365},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Wiener Medizinische Wochenschrift 2018
Citation only
Sarcopenia
Clinics in Geriatric Medicine 2010
Citation only
Sarcopenia
Clinics in Geriatric Medicine 2017
Citation only
Sarcopenia
Nature Reviews Disease Primers 2024
Citation only
Sarcopenia
The Lancet 2019
Citation only
Sarcopenia
Joint Bone Spine 2018
Open access · OA